FI59796C - Foerfarande foer framstaellning av antiulceroesa 5-fenoxi-4-aminopyrimidiner - Google Patents
Foerfarande foer framstaellning av antiulceroesa 5-fenoxi-4-aminopyrimidiner Download PDFInfo
- Publication number
- FI59796C FI59796C FI2796/73A FI279673A FI59796C FI 59796 C FI59796 C FI 59796C FI 2796/73 A FI2796/73 A FI 2796/73A FI 279673 A FI279673 A FI 279673A FI 59796 C FI59796 C FI 59796C
- Authority
- FI
- Finland
- Prior art keywords
- phenoxy
- solution
- phenoxypyrimidine
- preparation
- hours
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US287423A US3862190A (en) | 1972-09-08 | 1972-09-08 | 5-(unsubstituted and substituted phenoxy)-4-amino pyrimidines |
| US28742372 | 1972-09-08 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI59796B FI59796B (fi) | 1981-06-30 |
| FI59796C true FI59796C (fi) | 1981-10-12 |
Family
ID=23102839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI2796/73A FI59796C (fi) | 1972-09-08 | 1973-09-07 | Foerfarande foer framstaellning av antiulceroesa 5-fenoxi-4-aminopyrimidiner |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US3862190A (es) |
| JP (1) | JPS5543463B2 (es) |
| AR (1) | AR202106A1 (es) |
| AU (1) | AU471279B2 (es) |
| BE (1) | BE804414A (es) |
| CA (1) | CA996116A (es) |
| CH (1) | CH581121A5 (es) |
| DE (1) | DE2344611A1 (es) |
| ES (1) | ES418567A1 (es) |
| FI (1) | FI59796C (es) |
| FR (1) | FR2198753B1 (es) |
| GB (1) | GB1434805A (es) |
| NL (1) | NL7312270A (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3941889A (en) * | 1972-09-08 | 1976-03-02 | Pfizer Inc. | 5-(Substituted phenoxy)-4-amino pyrimidines as anti-ulcer agents |
| JPS57164686U (es) * | 1981-04-11 | 1982-10-16 | ||
| JPS6197973U (es) * | 1984-12-03 | 1986-06-23 | ||
| JPS63135868U (es) * | 1987-02-26 | 1988-09-06 | ||
| WO1998014430A1 (fr) * | 1996-10-02 | 1998-04-09 | Sumitomo Pharmaceuticals Co., Ltd. | Derives de pyrimidine |
| US6440965B1 (en) * | 1997-10-15 | 2002-08-27 | Krenitsky Pharmaceuticals, Inc. | Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system |
| US6583148B1 (en) | 1999-04-08 | 2003-06-24 | Krenitsky Pharmaceuticals, Inc. | Neurotrophic substituted pyrimidines |
| US7205297B2 (en) * | 2000-07-24 | 2007-04-17 | Krenitsky Pharmaceuticals, Inc. | Substituted 5-alkynyl pyrimidines having neurotrophic activity |
| WO2012086768A1 (ja) | 2010-12-24 | 2012-06-28 | 日本農薬株式会社 | ベンジルオキシピリミジン誘導体及び該誘導体を含有する農園芸用殺虫剤並びにその使用方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB886693A (en) * | 1959-03-04 | 1962-01-10 | Ici Ltd | Heterocyclic compounds |
-
1972
- 1972-09-08 US US287423A patent/US3862190A/en not_active Expired - Lifetime
-
1973
- 1973-08-29 CA CA179,926A patent/CA996116A/en not_active Expired
- 1973-08-31 GB GB4121973A patent/GB1434805A/en not_active Expired
- 1973-09-04 BE BE1005334A patent/BE804414A/xx not_active IP Right Cessation
- 1973-09-05 CH CH1276273A patent/CH581121A5/xx not_active IP Right Cessation
- 1973-09-05 AU AU60031/73A patent/AU471279B2/en not_active Expired
- 1973-09-05 DE DE19732344611 patent/DE2344611A1/de not_active Withdrawn
- 1973-09-06 NL NL7312270A patent/NL7312270A/xx not_active Application Discontinuation
- 1973-09-07 AR AR249980A patent/AR202106A1/es active
- 1973-09-07 FI FI2796/73A patent/FI59796C/fi active
- 1973-09-07 ES ES418567A patent/ES418567A1/es not_active Expired
- 1973-09-07 FR FR7332346A patent/FR2198753B1/fr not_active Expired
- 1973-09-08 JP JP10158973A patent/JPS5543463B2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS4992080A (es) | 1974-09-03 |
| AR202106A1 (es) | 1975-05-15 |
| CH581121A5 (es) | 1976-10-29 |
| DE2344611A1 (de) | 1974-03-14 |
| AU471279B2 (en) | 1976-04-15 |
| AU6003173A (en) | 1975-03-06 |
| US3862190A (en) | 1975-01-21 |
| JPS5543463B2 (es) | 1980-11-06 |
| FI59796B (fi) | 1981-06-30 |
| GB1434805A (en) | 1976-05-05 |
| ES418567A1 (es) | 1976-08-01 |
| FR2198753B1 (es) | 1976-09-03 |
| FR2198753A1 (es) | 1974-04-05 |
| CA996116A (en) | 1976-08-31 |
| NL7312270A (es) | 1974-03-12 |
| BE804414A (fr) | 1974-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI73433B (fi) | Foerfarande foer framstaellning av farmakologiskt vaerdefulla imidazo/1,2-a/pyraziner. | |
| SU1349700A3 (ru) | Способ получени (2-оксо-1,2,3,5-тетрагидроимидазо-/2,1- @ /хиназолинил)оксиалкиламидов,их оптических изомеров или фармакологически приемлемых солей с кислотами | |
| SU1375127A3 (ru) | Способ получени производных 1,2-диаминоциклобутен-3,4-диона или их хлоргидратов | |
| SU1240356A3 (ru) | Способ получени производных тиазолидина | |
| CZ281868B6 (cs) | Bis-naftalimidy, způsob jejich výroby a farmaceut ické přípravky na jejich bázi | |
| FI59796C (fi) | Foerfarande foer framstaellning av antiulceroesa 5-fenoxi-4-aminopyrimidiner | |
| US4968701A (en) | 4-Quinoline carboxylic acid derivatives useful as immunosuppressive agents | |
| EP0218027A1 (en) | Novel guanidinomethylbenzoic acid derivatives | |
| SU1574177A3 (ru) | Способ получени производных 4,5-дигидрооксазолов | |
| US4180588A (en) | Immunosuppressant | |
| US4939164A (en) | Strontium salt | |
| SU1657057A3 (ru) | Способ получени имидазолпроизводных или их фармацевтически приемлемых солей с кислотами | |
| EP0425283B1 (en) | Novel triazolyl hydrazide derivatives and process for their preparation | |
| EP0618901B1 (en) | Highly water soluble bis-naphthalimides useful as anticancer agents | |
| US4515806A (en) | Furan derivatives and addition salts thereof pharmaceutical compositions and the therapeutical applications thereof | |
| CA2204007A1 (en) | Remedy for diseases caused by infection with helicobacter | |
| FI68220B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbar n-(1-metyl-2-pyrrolidinylmetyl)-2,3-dimetoxi-5-metylsulfamoylbensamid | |
| US3941889A (en) | 5-(Substituted phenoxy)-4-amino pyrimidines as anti-ulcer agents | |
| SK695188A3 (en) | Enolether amide 1,1-dioxo-6-chloro-4-hydroxy-2-methyl-n-(2- -pyridyl)-2h-thieno (2,3-e)-1,2-thiazine-3-carboxylic acid, method of its production and pharmaceutical agent | |
| SU791241A3 (ru) | Способ получени производных 4,5,6,7-тетрагидроимидазо 4,5-с пиридина | |
| JPH0114235B2 (es) | ||
| SU1001855A3 (ru) | Способ получени 2-замещенных-1н-фенантро[9,10- @ ]имидазолов или их солей | |
| US3814766A (en) | 11-deoxoglycyrrhetinic acid piperazides useful as antiulcer agents | |
| US5489609A (en) | 2-aminoethanesulfonic acid zinc complex compound | |
| SU1217258A3 (ru) | Способ получени производных 2-гуанидино-4-гетероарилтиазола или их фармацевтически приемлемых кислотно-аддитивных солей |